- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 144-158 of
195 results
1009 Exhibit: Auchus Crinecerfont Lowers Elevated Hormone Markers in Adults Wit...
Document
PGR2022-00025, No. 1009 Exhibit - Auchus Crinecerfont Lowers Elevated Hormone Markers in Adults With 21 Hydroxylase Deficiency Congenital Adrenal Hyperplasia (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1040 Exhibit: Reif Mechanisms Involved in Placebo and Nocebo Responses and Im...
Document
PGR2022-00025, No. 1040 Exhibit - Reif Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1038 Exhibit: Fuqua Duration of Suppression of Adrenal Steroids after Glucocortico...
Document
PGR2022-00025, No. 1038 Exhibit - Fuqua Duration of Suppression of Adrenal Steroids after Glucocorticoid Administration (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1015 Exhibit: El Maouche Congenital Adrenal Hyperplasia
Document
PGR2022-00025, No. 1015 Exhibit - El Maouche Congenital Adrenal Hyperplasia (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1012 Exhibit: US Patent No 8,030,304 to Chen et al
Document
PGR2022-00025, No. 1012 Exhibit - US Patent No 8,030,304 to Chen et al (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1022 Exhibit: Merke Future Directions in the Study and Management of Congenital ...
Document
PGR2022-00025, No. 1022 Exhibit - Merke Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21 Hydroxylase Deficiency (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1032 Exhibit: Goodman Gilmans The Pharmacological Basis of Therapeutics
Document
PGR2022-00025, No. 1032 Exhibit - Goodman Gilmans The Pharmacological Basis of Therapeutics (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1005 Exhibit: Declaration of Robert M Carey
Document
PGR2022-00025, No. 1005 Exhibit - Declaration of Robert M Carey (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1020 Exhibit: Gully et al
Document
PGR2022-00025, No. 1020 Exhibit - Gully et al (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1006 Exhibit: US Patent Application Publication No 20170020877 to Grigoriadis et ...
Document
PGR2022-00025, No. 1006 Exhibit - US Patent Application Publication No 20170020877 to Grigoriadis et al (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1035 Exhibit: Bale Overview on Therapeutic Applications of Microparticulate Drug D...
Document
PGR2022-00025, No. 1035 Exhibit - Bale Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1025 Exhibit: Turcu Novel Treatment Strategies in Congenital Adrenal Hyperplasia
Document
PGR2022-00025, No. 1025 Exhibit - Turcu Novel Treatment Strategies in Congenital Adrenal Hyperplasia (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1030 Exhibit: Zorrilla Progress in Corticotropin Releasing Factor 1 Antagonist Deve...
Document
PGR2022-00025, No. 1030 Exhibit - Zorrilla Progress in Corticotropin Releasing Factor 1 Antagonist Development (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1014 Exhibit: Turcu The Next 150 Years of Congenital Adrenal Hyperplasia
Document
PGR2022-00025, No. 1014 Exhibit - Turcu The Next 150 Years of Congenital Adrenal Hyperplasia (P.T.A.B. Feb. 18, 2022)
|
|
Cite Document
1027 Exhibit: Neurocrine Biosciences to Present New Data Analyses for Crinecerfo...
Document
PGR2022-00025, No. 1027 Exhibit - Neurocrine Biosciences to Present New Data Analyses for Crinecerfont in Adults with Classical Congenital Adrenal Hyperplasia at ENDO 2021 (P.T.A.B. Feb....
|
|
Cite Document
